Læknablaðið - 15.03.2002, Blaðsíða 16

FRÆÐIGREINAR / EITILÆXLI í BRISI
án þess að til viðamikillar skurðaðgerðar þurfi að
koma. I sumum tilvikum, þar sem fyrirferð í briskirtli
er án meinsemda annars staðar, er mikilvægt að ná
góðu vefsýni fyrir frekara mat, rétta greiningu og
meðferðaráætlun.
Þakkir
Halldóri K. Valdimarssyni ljósmyndara á Landspítala
er þökkuð aðstoð við myndir í greinina. Einnig fá
Kristrún Benediktsdóttir læknir á Rannsóknarstofu
háskólans í meinafræði og Einar Jónmundsson lækn-
ir á röntgendeild Landspítala Hringbraut þakkir fyrir
veitta aðstoð.
Heimildir
1. Extrahepatic biliary obstruction: systemic effects, diagnosis
and manegement. In: Oxford Textbook of Clinical Hepato-
logy. Eds. Mclntyre N Denhamon JP, Birchner J, Rizzetto M,
Rodes J. Oxford 1991; 1139.
2. Barkun JS, Barkun AN. Scientific american surgery 2000.
Jaundice, approach to the jaundiced patient. CD-ROM,
Chapter 5.
3. YamaguchiK, Enjoji M. Carcinoma of the ampulla of vater. A
clinicopathologic study and pathological staging of 109 cases
of carcinoma and 5 cases of adenoma. Cancer 1987; 59:505-16.
4. Tompkins RK, Saunders K, Roslyn JJ, Longwire WP Jr.
Changing patterns in diagnosis and management of bile duct
canser. Ann Surg 1990; 211: 614-20.
5. Isaacson P, Wright DH. Extranodal malignant lymphoma
arising from mucosa-associated lymphoid tissue. Cancer 1984;
53 :2515-24.
6. Misdraji J, Fernandez del Castillo C, Ferry JA. Follicle center
lymphoma of the ampulla of Vater presenting with jaundice:
report of a case. Am J Surg Pathol 1997; 21; 484-8.
7. Mofredj A, Cadranel JF, Cazier A, Traore I, Coutarel P, Levy
P. [Malignant pancreatic non-hodgkin's lymphoma manifes-
ting as severe acute pancreatitis.] Gastroenterol Clin Biol
1999; 23: 528-31. Á frönsku.
8. Cappell MS, Yao F, Cho KC, Axiotis CA. Lymphoma predo-
minantly involving the pancreas. Dig Dis Sci 1989; 34: 942-7.
9. Pecorari P, Gorji N, Melato M. Primary non-Hodgkin's
lymphoma of the head of the pancreas: a case report and
review of literature. Oncol Rep 1999; 6:1111-5.
10. Baylor SM, Berg JW. Cross-classification and survival charac-
teristics of 5,000 cases of cancer of the pancreas. J Surg Oncol
1973;5:335-58.
11. Pawade J, Lee CS, Ellis DW, Vellar ID, Rode J. Primary
lymphoma of the ampulla of Vater. Cancer 1994; 73: 2083-6.
12. Scully RE, Mark EJ, McNeely BU. Case records of the Massa-
chussetts general hospital (case 11-1985): N Engl J Med 1985;
312: 706-11.
13. Ahlgreen JD. Epidemiology and risk factors in pancreatic
cancer. Seminar in oncology 1996; 241-50.
14. Arnar DO, Theodors A, Isaksson HJ, Gunnlaugsson GH,
Tulinius H, Johannsson H, Kjartansson S. Cancer of the
pancreas in Iceland. An epidemiologic and clinical study, 1974-
85. Scand J Gastroenterol 1991; 26: 724-30.
15. Cario E, Runzi M. Metz K, Layer P, Goebell H. Diagnostic
dilemma in pancreatic lymphoma. Case report and review. Int
J Pancreatol 1997; 22: 67-71.
16. Webb TH, Lillemoe KD, Pitt HA, Jones RJ, Cameron JL.
Pancreatic lymphoma. Is surgery mandatory for diagnosis or
treatment? Ann Surg 1989; 209: 25-30.
17. Prayer L, Schurawitzki H, Mallek R, Mostbeck G. CT in
pancreatic involvement of non-Hodgkin lymphoma. Acta
Radiol 1992; 33:123-7.
18. Tikkakoski T, Siniluoto T, Paivansalo M, Typpo T, Turunen J,
Apaja-Sarkkinen M. Diagnostic accuracy of ultrasound-
guided fine-needle pancreatic biopsy. Rofo Fortschr Geb
Rontgenstr Neuen Bildgeb Verfahr 1992; 156:178-81.
19. Dinkel E, Helwig A, Jager B, Ruckauer K, Scholmerich J,
Hauenstein KH, Wimmer B. [Computed tomographic-guided
fine-needle biopsy of the pancreas for histology determina-
tion.] Radiologe 1990; 30: 420-4. Á þýsku.
20. Ackerman NB, Aust JC, Bredenberg CE, Hanson VA Jr,
Rogers LS. Problems in differentiating between panceratic
lymphoma and anaplastic carcinoma and their management.
Ann Surg 1976; 184: 705-8.
21. Borrowdale R, Strong RW. Primary lymphoma of the panc-
reas. Aust N Z J Surg 1994; 64: 444-6.
22. Brown PC, Hart MJ, White TT. Pancreatic lymphoma, diag-
nosis and management. Int J Pancreatol 1987; 2: 93-9.
23. Gawdat K, Howe K. Pancreatic lymphoma. J Clin Gastro-
enterol 1993; 16: 258-60.
24. Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM,
Mize EM, et al. Comparison of a standard regimen (CHOP)
with three intensive chemotherapy regimens for advanced
non-Hodgkin's lymphoma. N Engl J Med 1993; 328:1002-6.
25. Miller TP, Dahlberg S, Cassady JR, Adelstein DJ, Spier CM,
Grogan TM, et al. Chemotherapy alone compared with
chemotherapy plus radiotherapy for localized intermediate-
and high-grade non-Hodgkin's lymphoma. N Engl J Med
1998; 339: 21-6.
26. Fisher RI, De Vita VT, Young RC. Advances in the treatment
of diffuse aggressive lymphomas. In RJ Ford, LM Fuller, FB
Hagemeister (eds.). University of Texas (Houston) M.D.
Anderson Clinical Conference on Cancer, 1984; 27: 377-90.
27. Shipp M. Prognostic factors in aggressiv non Hodgkins lymp-
homa, who has “high risk” disease ?. Blood 1994; 83:1165-73.
28. International non Hodgkins lymphoma prognostic factors pro-
ject: A predictive model for aggressive non Hodgkins lymp-
homa. NEJM 1993; 329 : 987.
29. James JA, Milligan DW, Morgan GJ, Crocker J. Familial
pancreatic lymphoma. J Clin Pathol 1998; 51:80-82.
30. Summary of Pancreas Club Meeting. Am J Surg 1992; 164:315-
320.
31. Benning TL, Silverman JF, Berns LA, Geisinger KR. Fine
needle aspiration of metastatic and hematologic malignancies
clinically mimicking pancreatic carcinoma. Acta Cytol 1992;
36: 471-6.
32. Whipple AO. The rationale for radical surgery for cancer of
the pancreas and ampullay region. Ann Surg 1941; 114: 612.
33. Conrad A, Rios G, Cole D, Adams D, Leveen M, O'Brien P, et
al. Trends in indications and outcomes in the Whipple proce-
dure over a 40-year period. Am Surg 1999; 65: 889-93.
34. Birkmeyer JD, Finlayson SR, Tosteson AN, Sharp SM,
Warshaw AL, Fisher ES. Effect of hospital volume on in-
hospital mortality with pancreaticoduodenectomy. Surgery
1999; 125: 250-6.
35. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A,
Sauter PK, et al. Pancreaticoduodenectomy. Does it have a
role in the palliation of pancreatic cancer? Ann Surg 1996;
223:718-25.
36. Gudjonson B. Critical look at resection for pancreatic cancer.
Lancet 1996; 348; 1676.
37. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH,
Goodman SN, et al. Pancreaticoduodenectomy for cancer of
the head of the pancreas. 201 patients. Ann Surg 1995; 221:
721-31.
38. Romaguera J, Velasques W, Silvermintz K et. al. Surgical
debukling is associated with improved survival in stage 1-2
large cell lymphoma. Cancer 1990; 66: 267.
39. Moossa AR. Pancreatic cancer: approach to diagnosis. Selec-
tion for surgery and choice of operation. Cancer 1982; 50:
2689-98.
40. Rege RV. Adverse effects of biliary obstruction: implications
for treatment of patients with obstructive jaundice. AJR Am
J Roentgenol 1995; 164: 287-93.
41. Smith AC , Dowsett JF, Russel RC, Hatfield AR, Cotton PB.
Randomised trial of endoscopic stenting versus surgical by-
pass in malignant low bileduct obstruction. Lancet 1994; 344:
1655-60.
42. McPherson GA, Benjamin IS, Hodgson HJ, Bowley NB,
Allison DJ, Blumgart LH. Pre-operative percutaneous trans-
hepatic biliary drainage: the results of a controlled trial. Br J
Surg 1984; 71: 371-5.
43. Hanyu F. One thousand pancreatoduodenectomies at a single
institution. In: Hanyu F Takasaki K (eds) Pancreaticoduo-
denectomy. Springer Tokyo 1997; 13-21.
44. Crist DW, Sitzmann JV, Cameron JL. Improved hospital mor-
bidity, mortality, and survival after Whipple procedure. Ann
Surg 1987; 206: 358-65.
192 Læknablaðið 2002/88